KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Invested Capital (2016 - 2025)

Historic Invested Capital for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $361.2 million.

  • Biolife Solutions' Invested Capital rose 454.86% to $361.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $361.2 million, marking a year-over-year increase of 454.86%. This contributed to the annual value of $364.8 million for FY2024, which is 92.39% up from last year.
  • According to the latest figures from Q3 2025, Biolife Solutions' Invested Capital is $361.2 million, which was up 454.86% from $357.2 million recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Invested Capital ranged from a high of $497.2 million in Q3 2021 and a low of $209.2 million during Q1 2021
  • For the 5-year period, Biolife Solutions' Invested Capital averaged around $386.7 million, with its median value being $365.6 million (2025).
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 33089.71% in 2021, then tumbled by 2068.48% in 2023.
  • Biolife Solutions' Invested Capital (Quarter) stood at $485.3 million in 2021, then dropped by 19.67% to $389.8 million in 2022, then fell by 7.26% to $361.5 million in 2023, then grew by 0.92% to $364.8 million in 2024, then decreased by 0.99% to $361.2 million in 2025.
  • Its Invested Capital stands at $361.2 million for Q3 2025, versus $357.2 million for Q2 2025 and $365.6 million for Q1 2025.